MarketInOut Stock Screener Log In | Sign Up

Big Pharma Split Corp

TSX • Financial Services • Asset Management • Quote as of 10/27/2026 13:27
Big Pharma Split Corp stock price and volume chart

Company Profile

IndustryAsset Management
SectorFinancial Services
ExchangeTSX
Market Capitalization19.71 mln
Float1.31 mln

Piotroski F-Score

4 / 9
Borderline

Relative Strength

93 / 100
Top performer

Debt / Equity

0.67
Moderate leverage

Pre-Tax Margin

862%
Exceptional margin

ROE

39.88
Very strong

Dividend Yield

8.13%
Unsustainable?

Business Description

Harvest Portfolios Group Inc. launched and manages Big Pharma Split Corp, a Canadian closed-end fund established in September 2017. The fund focuses on publicly traded pharmaceutical companies based in the United States.

Key Fundamentals

EPS-1.95
ROE39.88
RPS2.86
ROIC54.79
ROA22.26
Interest Cover11.20
EBITDA, mln7.42
EV / EBITDA-0.04
EV / EBIT-0.04
Revenue, mln0.78

Quote Details

Last 15.50
Change 0.24 (1.57%)
Open 15.25
Volume 1,515
Turnover 23,482
Average Volume 1,089.62

Financial Ratios

Pre-Tax Profit Margin862
Leverage Ratio1.72
Current Ratio2.44
Price / Book1.01
Price / Tangible Book1.01
Debt / Equity0.67
Price / Sales25.48

Financial Strength

Altman Z-Score2.12
Piotroski F-Score 4 / 9
Price to Intrinsic Value3.78
Price to Graham Number0.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.33% 91 / 100   
1 Month 8.08% 90 / 100   
2 Months 11.86% 84 / 100   
6 Months 16.85% 85 / 100   
1 Year 45.29% 87 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog